Lilly to Participate in Goldman Sachs Global Healthcare Conference

INDIANAPOLIS, June 9, 2014 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) will attend the Goldman Sachs 35th Annual Global Healthcare Conference on Wednesday, June 11th, 2014. David Ricks, Lilly senior vice president and president of Lilly Bio-Medicines, will participate in a fireside chat at 1:40 p.m. EDT.

A live audio webcast will be available on the Webcasts & Presentations section of Lilly's Investor website at http://investor.lilly.com/events.cfm. Subsequently, a replay of the fireside chat with Mr. Ricks will be available on this same website for approximately 30 days.

About Eli Lilly and Company
Lilly is a global healthcare leader that unites caring with discovery to make life better for people around the world. We were founded more than a century ago by a man committed to creating high-quality medicines that meet real needs, and today we remain true to that mission in all our work. Across the globe, Lilly employees work to discover and bring life-changing medicines to those who need them, improve the understanding and management of disease, and give back to communities through philanthropy and volunteerism. To learn more about Lilly, please visit us at www.lilly.com and http://newsroom.lilly.com/social-channels. F-LLY

Refer to: 

(317) 276-5795 – Mark Taylor (Media)


(317) 655-6874 – Philip Johnson (Investors)

 

Eli Lilly and Company logo.

 

http://photos.prnewswire.com/prnh/20031219/LLYLOGO  

 

SOURCE Eli Lilly and Company

Suggested Articles

Enhertu cut the risk of death by 41% compared with chemo in previously treated HER2-positive gastric cancer.

CanSino reports positive data for COVID-19 vaccine. Takeda's Alunbrig wins first-line lung cancer nod. GSK inks $231 million deal with Samsung.

Gilead is working to move CAR-T med Yescarta into other types of NHL, and if data from an interim trial look-in are any indication, it's on its way.